LANGEN

DGAP-News: Paul Ehrlich Institute Allows Heidelberg Pharma to Start a Phase I/IIa Clinical Trial with ATAC Candidate HDP-101

Retrieved on: 
Monday, July 19, 2021
In Germany, In science, Paul Ehrlich Institute, the Phase I/IIa study with HDP-101, Heidelberg Pharma, THE PHASE I/IIA STUDY WITH HDP-101, HEIDELBERG PHARMA

Ladenburg, Germany, 19 July 2021 - Heidelberg Pharma AG (FSE: HPHA) today announced that the German authority Paul Ehrlich Institute, Langen, Germany, (PEI) has approved the study design of the planned Phase I/IIa clinical trial with the ATAC candidate HDP-101.

Key Points: 
  • Ladenburg, Germany, 19 July 2021 - Heidelberg Pharma AG (FSE: HPHA) today announced that the German authority Paul Ehrlich Institute, Langen, Germany, (PEI) has approved the study design of the planned Phase I/IIa clinical trial with the ATAC candidate HDP-101.
  • After approval by the ethics committee and signing the contracts, we will soon start with the initiation of the German study centers.
  • The first part of the trial is a Phase I dose escalation study to determine the maximum tolerated dose of HDP-101.
  • The proprietary lead candidate HDP-101 is a BCMA ATAC for multiple myeloma and will enter clinical development shortly.

DGAP-News: Further expansion in the area of buses: AKASOL concludes long-term framework agreement with a Belgian bus manufacturer in the mid-double-digit million euro range

Retrieved on: 
Friday, July 16, 2021
Bus, Electric bus, Intermodal container

Further expansion in the area of buses: AKASOL concludes long-term framework agreement with a Belgian bus manufacturer in the mid-double-digit million euro range

Key Points: 
  • Further expansion in the area of buses: AKASOL concludes long-term framework agreement with a Belgian bus manufacturer in the mid-double-digit million euro range
    The issuer is solely responsible for the content of this announcement.
  • "We are proud that one of the largest European bus manufacturers has now also chosen AKASOL as a strategic partner for the consistent electrification of its portfolio," explained AKASOL CEO Sven Schulz.
  • AKASOL will supply the second generation of AKASystem 15 OEM 50 PRC high-performance battery systems for the new electric bus to start with.
  • In addition, further cross-selling potential could arise in the long term if the Belgian manufacturer also electrifies other segments of its portfolio - such as trailers or tank containers.

DGAP-News: AKASOL AG: 2021 Virtual Annual General Meeting held

Retrieved on: 
Wednesday, June 30, 2021
Chemistry, Physical sciences, Auburn Hills, Michigan, BorgWarner, Natural sciences, Lithium

Darmstadt, Germany, June 30, 2021 - AKASOL AG ("AKASOL"; ISIN DE000A2JNWZ9), a leading German developer and manufacturer of high-energy and high-performance lithium-ion battery systems for buses, commercial vehicles, rail vehicles, industrial vehicles, ships and boats, and a provider of comprehensive solutions, held its 2021 Annual General Meeting today, on Wednesday.

Key Points: 
  • Darmstadt, Germany, June 30, 2021 - AKASOL AG ("AKASOL"; ISIN DE000A2JNWZ9), a leading German developer and manufacturer of high-energy and high-performance lithium-ion battery systems for buses, commercial vehicles, rail vehicles, industrial vehicles, ships and boats, and a provider of comprehensive solutions, held its 2021 Annual General Meeting today, on Wednesday.
  • The annual shareholder meeting was once again held as a virtual event in the second year of the COVID-19 pandemic.
  • BorgWarner has since become the largest shareholder of AKASOL AG and has held at least 89.08% of the shares since the transaction was completed on June 4, 2021.
  • The Annual General Meeting expressed its confidence in the members of the Management Board and Supervisory Board and discharged them by a large majority.

DGAP-News: AKASOL AG: Still on course for dynamic growth - despite the coronavirus crisis: AKASOL boosts revenue by more than 40% to EUR 68.3 million in 2020

Retrieved on: 
Friday, April 30, 2021

In this connection, revenue of EUR 50.1 million in the second half of 2020 alone represented more than a doubling compared to the first half of 2020 (EUR 18.2 million).

Key Points: 
  • In this connection, revenue of EUR 50.1 million in the second half of 2020 alone represented more than a doubling compared to the first half of 2020 (EUR 18.2 million).
  • AKASOL launched production there of the second generation of battery systems in the second half of 2020.
  • We continued to grow in 2020, not just in our corporate structures but in our revenue volume as well.
  • Quite the contrary: In the 4th quarter, we recorded the highest revenue in the history of the Company at EUR 27.8 million.

DGAP-News: AKASOL AG: Unanimous recommendation of acceptance of the takeover offer by BorgWarner subsidiary ABBA BidCo AG

Retrieved on: 
Wednesday, April 7, 2021
Auburn Hills, Michigan, BorgWarner, Societates Europaeae, Companies, MAN SE, Manufacturing, Industrial organization

Darmstadt, April 7, 2021 - Today, the Management Board and Supervisory Board of AKASOL AG ("AKASOL;" the "Company;" ISIN DE000A2JNWZ9) published their reasoned opinions on the voluntary public takeover offer by ABBA BidCo AG, a subsidiary of BorgWarner Inc. (together "BorgWarner").

Key Points: 
  • Darmstadt, April 7, 2021 - Today, the Management Board and Supervisory Board of AKASOL AG ("AKASOL;" the "Company;" ISIN DE000A2JNWZ9) published their reasoned opinions on the voluntary public takeover offer by ABBA BidCo AG, a subsidiary of BorgWarner Inc. (together "BorgWarner").
  • In their statements, the boards welcome and support the offer and recommend the acceptance of the offer to AKASOL's shareholders.
  • The offer document was published by the BorgWarner subsidiary ABBA BidCo AG at https://abba-angebot.de/websites/1051_ma/English/1000/announcements.html.
  • Sven Schulz (via Schulz Group GmbH) and the other founders of AKASOL, representing 59.4% of shares in AKASOL, have already accepted the offer of ABBA BidCo AG.